Physician profile
Brett Lebed
NPI 1962664409
$10,539.37
in general payments reported to CMS, 2019-2025
55 companies · $2,254 in 2025
The $2,254 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,218 · 2020: $817 · 2021: $1,053 · 2022: $1,251 · 2023: $2,150 · 2024: $1,796 · 2025: $2,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,848 · Travel and Lodging: $191 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,847.92 |
| Travel and Lodging | $191.44 |
| Education | $160.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,099.57 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $940.54 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $738.36 | 2020-2025 | Myrisk, Prolaris |
| Bluewind Medical | $662.44 | 2024-2025 | Revi |
| Pfizer INC. | $620.93 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $567.31 | 2019-2025 | |
| Astellas Pharma US INC | $530.66 | 2019-2025 | Xtandi, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $368.83 | 2022-2025 | Lynparza, Imfinzi |
| Janssen Biotech, INC. | $367.99 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Axonics, INC. | $344.32 | 2021-2024 | Axonics, Bulkamid |
| Coloplast Corp | $317.75 | 2019-2022 | |
| Urovant Sciences INC | $294.30 | 2022 | |
| Novartis Pharmaceuticals Corporation | $224.26 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $202.51 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $198.76 | 2021-2025 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $193.36 | 2019-2022 | |
| Immunitybio, INC. | $185.65 | 2025 | |
| Ferring Pharmaceuticals INC. | $165.73 | 2019-2025 | Adstiladrin |
| Sanara Medtech INC. | $155.71 | 2021 | |
| Progenics Pharmaceuticals, INC. | $151.37 | 2025 | |
| Amgen INC. | $139.64 | 2019-2022 | |
| Procept Biorobotics Corporation | $139.55 | 2023-2025 | Aquabeam Robotic System |
| Olympus America INC. | $122.39 | 2022-2024 | Itind System |
| Tolmar Pharmaceuticals, INC. | $115.90 | 2020-2022 | |
| Biotissue Holdings INC. | $112.90 | 2025 | |
| Seagen INC. | $99.99 | 2025 | |
| Laborie Medical Technologies Corp. | $94.59 | 2023 | |
| Neotract INC. | $89.34 | 2019 | |
| Blue Earth Diagnostics | $89.34 | 2022-2024 | |
| Antares Pharma, INC. | $85.16 | 2023-2024 | Xyosted, Nocdurna, Tlando |
| Sun Pharmaceutical Industries INC. | $83.72 | 2019-2023 | Yonsa |
| Photocure INC | $73.08 | 2023 | Cysview |
| Myovant Sciences INC. | $68.39 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $64.72 | 2021-2025 | Lynparza |
| Baudax Bio INC. | $63.52 | 2020-2021 | |
| Verity Pharmaceuticals INC. | $62.02 | 2023-2025 | Trelstar, Tlando |
| Medtronic USA, INC. | $57.31 | 2019-2020 | |
| Endo USA, INC. | $56.81 | 2025 | Xiaflex |
| Amag Pharmaceuticals, INC. | $55.24 | 2019 | |
| Therapeuticsmd, INC. | $52.41 | 2019-2020 | |
| Foundation Medicine, INC. | $51.75 | 2020-2022 | |
| Boston Scientific Corporation | $51.37 | 2021-2025 | Axonics |
| Ethicon US, LLC | $51.20 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $48.07 | 2019-2020 | |
| Philips North America LLC | $45.37 | 2022 | |
| Teleflex LLC | $42.90 | 2024 | Urolift |
| Accord Healthcare, INC. | $33.03 | 2025 | |
| Alnylam Pharmaceuticals INC. | $28.66 | 2024 | Oxlumo |
| Becton, Dickinson and Company | $23.28 | 2024 | Bard Urinary Drainage Bag |
| Angiodynamics, INC. | $20.85 | 2023 | Nanoknife |
| Caldera Medical, INC | $20.72 | 2025 | |
| Medtronic, INC. | $18.62 | 2021 | |
| Tolmar, INC. | $17.88 | 2023 | |
| Conmed Corporation | $15.03 | 2024 | Airseal |
| Dentsply Ih INC. | $14.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Lebed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.